Multiple studies show the combination potential of vedotin antibody-drug conjugates (ADCs) with pembrolizumab, including the first Phase 1 data in thoracic cancers for two first-in-class ADCs
Durable pain relief from a single MM-II injection and its cartilage-protective effects in OA modelsfeatured in two peer-reviewed articles
The company delivered revenues of Rs. 5,554 crore, representing 10% growth in FY25
A new weapon in the global fight against malaria
SmartTrack aims to reduce the need for clinical studies in generic drug product approvals
Zydus MedTech gets rights to market the innovative Transcatheter Aortic Valve Implantation (TAVI) technology in India, Europe and other select markets
Feldan's proprietary Shuttle peptide technology enables the efficient and targeted delivery of biomolecules into cells, unlocking new therapeutic possibilities
Centre for Continuous Manufacturing and Advanced Crystallisation (CMAC) aims to accelerate the digital transformation of CMC development and manufacturing approaches
The approval was granted more than two months ahead of the Prescription Drug User Fee Act goal date
NATCO has decided to price the product at Rs.15, 900 MRP consistent with the company’s stand before the court
Subscribe To Our Newsletter & Stay Updated
